We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu
IMPORTANT: Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

The Vancouver-BOLD Study: The Burden of Chronic Obstructive Lung Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00136006
Recruitment Status : Unknown
Verified January 2013 by University of British Columbia.
Recruitment status was:  Active, not recruiting
First Posted : August 26, 2005
Last Update Posted : February 1, 2013
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
This is a study of the lung health of the population of Vancouver and the extent of, and the risk factors for, chronic obstructive lung disease.

Condition or disease Intervention/treatment
Chronic Obstructive Lung Disease Behavioral: Study to determine the burden of disease

Study Design

Study Type : Observational
Estimated Enrollment : 1000 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: The Burden of Chronic Obstructive Lung Disease (BOLD) Study
Study Start Date : August 2005
Estimated Primary Completion Date : December 2013
Estimated Study Completion Date : December 2013

Resource links provided by the National Library of Medicine

MedlinePlus related topics: COPD Lung Diseases
U.S. FDA Resources

Groups and Cohorts


Outcome Measures

Primary Outcome Measures :
  1. Lung health [ Time Frame: 10 years ]
    Lung health of the population of Vancouver and the extent of, and the risk factors for, chronic obstructive lung disease


Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   40 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Population of Vancouver, BC, Canada
Criteria

Inclusion Criteria:

  • 40 years of age and older
  • Both sexes
  • Random sample of population

Exclusion Criteria:

  • Contraindication for lung function testing and serious life threatening illness.
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00136006


Locations
Canada, British Columbia
St.Paul's Hospital/Providence Health Care
Vancouver, British Columbia, Canada, V5Z 1L8
Sponsors and Collaborators
University of British Columbia
Investigators
Study Director: Wen Wang University of British Columbia
More Information

Responsible Party: University of British Columbia
ClinicalTrials.gov Identifier: NCT00136006     History of Changes
Other Study ID Numbers: P05-0061
05-0965
First Posted: August 26, 2005    Key Record Dates
Last Update Posted: February 1, 2013
Last Verified: January 2013

Keywords provided by University of British Columbia:
Epidemiology
Lung health
lung function
COPD

Additional relevant MeSH terms:
Lung Diseases
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Respiratory Tract Diseases